Halozyme Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Halozyme Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Halozyme Therapeutics Inc Strategy Report
- Understand Halozyme Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Halozyme Therapeutics Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Halozyme Therapeutics Inc’s relevant decision makers and contact details.
A sample of Halozyme Therapeutics Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 15 Aug 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 24 May 2022 | Mergers & Acquisitions | Halozyme Therapeutics Acquires Antares Pharma | Antares Pharma Inc | (estradiol + segesterone acetate); (ethinyl estradiol + norelgestromin); (segesterone acetate + testosterone); abiraterone acetate; AP-1126; AP-159; ATRS-1701; ATRS-1901; ATRS-1903; desmopressin acetate ODT; hydrocortisone; testosterone enanthate; testosterone undecanoate | Central Nervous System; Genito Urinary System And Sex Hormones; Hormonal Disorders; Immunology; Male Health; Metabolic Disorders; Oncology; Women's Health |
| 24 May 2022 | Mergers & Acquisitions | Halozyme Therapeutics Acquires Antares Pharma | Halozyme Therapeutics Inc | (estradiol + segesterone acetate); (ethinyl estradiol + norelgestromin); (segesterone acetate + testosterone); abiraterone acetate; AP-1126; AP-159; ATRS-1701; ATRS-1901; ATRS-1903; desmopressin acetate ODT; hydrocortisone; testosterone enanthate; testosterone undecanoate | Central Nervous System; Genito Urinary System And Sex Hormones; Hormonal Disorders; Immunology; Male Health; Metabolic Disorders; Oncology; Women's Health |
| 28 Apr 2022 | Expected Trial Initiations | Phase IV Trial Initiation Expected on 01-Apr-2024 | Antares Pharma Inc | testosterone undecanoate | Male Health |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer